Pneumonia Epidemiology Forecast 2025-2034

Pneumonia is the leading cause of death from infectious diseases among children, accounting for over 700,000 lives annually in children under 5, or approximately 2,000 every day. The highest incidence rates are reported in South Asia (2,500 per 100,000 children) and West and Central Africa (1,620 per 100,000 children).

Pneumonia Epidemiology Forecast Report Coverage

The “Pneumonia Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of pneumonia. It projects the future incidence and prevalence rates of pneumonia across various populations. The study covers age, gender, and type as major determinants of the pneumonia-affected population. The report highlights patterns in the prevalence of pneumonia over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of pneumonia in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Pneumonia: Disease Overview

Pneumonia is a serious lung infection that causes inflammation. It makes breathing difficult and reduces oxygen levels in the blood. It can be caused by bacteria, viruses, or fungi, with common pathogens including Streptococcus pneumoniae and respiratory syncytial virus (RSV). Symptoms include cough, fever, chest pain, and difficulty breathing. Although pneumonia can affect anyone, young children, the elderly, and individuals with weakened immune systems are more prone to develop the infection.

Pneumonia: Treatment Overview

The treatment approach for pneumonia is based on the cause, severity, and age of the patient. Antibiotics are the primary treatment for bacterial pneumonia. In severe cases, hospitalization may be required for intravenous antibiotics and supportive care. Antifungal medications are used for pneumonia caused by fungi, especially in individuals with weakened immune systems. Antiviral medications are prescribed for viral pneumonia.

Epidemiology

The pneumonia epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for pneumonia by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for pneumonia and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

• It is estimated that there are more than 1,400 pneumonia cases per 100,000 children, which indicates 1 in every 71 children gets pneumonia each year.
• According to the National Hospital Ambulatory Medical Care Survey (2021), there were 1.4 million visits to emergency departments in the United States for pneumonia, with an infectious organism as the primary diagnosis.
• In 2019, pneumonia was responsible for the death of 740,180 children under 5 years, as per the World Health Organization (WHO).
• A study in the Indian Journal of Respiratory Care (2022) found that the death rate for community-acquired pneumonia (CAP) in India is less than 5% for outpatients, about 10% for hospitalized patients, and can exceed 30% for patients in intensive care.

Country-wise Pneumonia Epidemiology

The pneumonia epidemiology data and findings from the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of pneumonia varies between countries, owing to differences in factors such as healthcare access, vaccination coverage, socioeconomic status, environmental conditions, nutrition, and public health infrastructure. According to the World Health Organization (WHO), India accounts for 23% of the global burden of community-acquired pneumonia (CAP).

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of pneumonia based on several factors.
• Pneumonia Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population and the unmet needs of pneumonia are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of pneumonia epidemiology in the 8 major markets?
• What will be the total number of patients with pneumonia across the 8 major markets during the forecast period?
• What was the country-wise prevalence of pneumonia in the 8 major markets in the historical period?
• Which country will have the highest number of pneumonia patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of pneumonia during the forecast period of 2025-2034?
• What are the currently available treatments for pneumonia?
• What are the disease risks, signs, symptoms, and unmet needs of pneumonia?

This product will be delivered within 3-5 business days.